Skip to main content

Table 3 Estimates of hazard ratios for recurrent disease

From: Gene expression of PMP22 is an independent prognostic factor for disease-free and overall survival in breast cancer patients

 

Univariate Analysis

Multivariable Analysis

Variable*

Hazard Ratio

95% Confidence Interval of Hazard Ratio

p

Hazard Ratio

95% Confidence interval of Hazard Ratio

p

EMP1

1.01

0.69 - 1.47

0.9738

   

EMP2

1.03

0.70 - 1.50

0.8930

   

EMP3

0.93

0.64 - 1.36

0.7275

   

PMP22

1.01

0.69 - 1.46

0.9780

1.77

1.09 - 2.87

0.0200

pT

1.32

0.99 - 1.78

0.0610

1.27

0.93 - 1.74

0.1367

pN

2.72

1.73 - 4.27

< 0.0001

2.72

1.69 - 4.38

< 0.0001

G

1.06

0.78 - 1.44

0.7033

0.98

0.70 - 1.38

0.9133

ER

0.63

0.43 - 0.92

0.0169

0.49

0.31 - 0.78

0.0025

  1. *The hazard ratios are indicated for: EMP1, EMP2, EMP3, and PMP22 (> median gene expression) vs. (≤median gene expression);
  2. (pT3+pT4) vs. (pT1+pT2); pN1 vs. pN0; (G2+G3) vs. G1; ER+ vs. ER-